San Diego, Calif., -- November 20, 2012 -- XIFIN Inc., the financial cloud computing company revolutionizing the business of healthcare diagnostics from patient to payment, today announced that the company ranked #308 on the Technology Fast 500™, a ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on percentage of fiscal year revenue growth during the period from 2007–2011.
"The companies on the Fast 500 list are among those that have demonstrated remarkable innovation, creativity and business savvy," said Bill Ribaudo partner, Deloitte & Touche LLP and national TMT leader for audit and enterprise risk services (AERS). "As a result, these companies have continued to successfully forge ahead in a challenging economic environment. We applaud the leadership and employees of XIFIN for this impressive accomplishment."
XIFIN's cloud-based platform, combined with its proven RCM solution, helps diagnostic service providers maximize profitability by capturing revenue faster and with greater efficiency. XIFIN's iNet platform leverages cloud computing to allow other software applications to easily access, share, search and analyze billing data to streamline the end-to-end billing process.
"We are thrilled to be listed on the Deloitte Fast 500 for the third consecutive year," stated Lâle White, CEO of XIFIN. "XIFIN’s record growth is a testament to our unique cloud-based technology platform, which is built from the ground up to enable the sharing of information in real time to improve profitability, drive better patient outcomes and lower healthcare costs. Our next-generation platform, expertise and managed services set us apart from the competition, and are an essential element in enabling providers to elevate diagnostic medicine as an integral function in disease and health management."
XIFIN processes more than 100 million claims per year across a wide variety of healthcare segments including clinical, hospital outreach, anatomic pathology, molecular diagnostics, toxicology, radiology and more. Customers see significant improvements in profitability by collecting 8 percent additional cash on average in the first 12 months, and have realized cumulative gains in excess of $1 billion in net cash collection, adjusted for growth.
For additional detail on the Technology Fast 500™ including selection and qualifying criteria, visit www.fast500.com.